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MinireviewSP-RING for SUMO:
New Functions Bloom for
a Ubiquitin-like Protein
that the SUMO-activating and -conjugating enzymes,
as well as the SUMO-deconjugating enzymes, were first
described (Figure 1; reviewed in Melchior, 2000). As with
ubiquitin, the C-terminal carboxyl group of SUMO ap-
pears to be activated by adenylation, in this case by the
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New Haven, Connecticut 06520 heterodimeric “E1-like” enzyme Uba2-Aos1; the SUMO-
AMP is thought to remain tightly bound to Uba2-Aos1.
In a second step, a thioester is formed between Uba2
and SUMO. The activated SUMO is transferred—again
like ubiquitin—to a cysteine side chain of the “E2-like”SUMO is covalently linked to a variety of cellular pro-
teins. Three groups now describe related E3-like fac- protein called Ubc9. Ubc9 then transfers its thioester-
linked SUMO to a substrate lysine residue. Both Uba2tors that enhance transfer of SUMO to specific proteins.
This family of factors includes proteins important for and Aos1 contain extended regions of sequence similar-
ity to the E1 for ubiquitin, and Ubc9 is so similar tochromosome condensation, signal transduction, and
ion channel biogenesis. ubiquitin-conjugating enzymes that it was originally mis-
taken for one.
Covalent attachment of one protein to another repre- To those who cut their teeth studying ubiquitin, two
features of SUMO ligation have seemed very peculiar.sents one of the more prominent posttranslational modi-
fications—in terms of both size and ubiquity—to which The first is the existence of a recognizable consensus
sequence—KxE, where  is an aliphatic residue—eukaryotic proteins are subject. Ubiquitin is the most
familiar of the proteinaceous protein modifiers, and the surrounding the substrate lysine(s) that is sumoylated.
No such consensus sequence has ever been found forenzymology of its activation and transfer to target mole-
cules has been studied extensively for over two de- ubiquitination targets, and for many substrates, the ubi-
quitin conjugation enzymes show a remarkable indiffer-cades. Much more recently, a sizeable group of ubiqui-
tin-related proteins have come to light, often as a result ence toward the particular lysine that is to be modified.
The second unusual aspect of sumoylation is that theof genome sequencing efforts. Many of these proteins
consist of ubiquitin-related domains that are stably built E1 and E2 enzymes (together with ATP and SUMO) ap-
pear to be sufficient in vitro for relatively robust modifi-into larger structures, and in some cases it is likely these
domains derive from independent protein lineages that cation of proteins at precisely the lysines that are pre-
ferred in vivo. For ubiquitin, an additional factor, calledhave converged on the ubiquitin fold because of its
intrinsic structural utility. However, at least a dozen dis- an E3 or ubiquitin-protein ligase, is almost always neces-
sary for efficient substrate ubiquitination, both in vitrotinct ubiquitin-like proteins (Ubls) do precisely what ubi-
quitin is so well known for doing: they form covalent and in vivo. An E3 has been defined as “an enzyme that
binds, directly or indirectly, specific protein substratesattachments to other macromolecules.
SUMO, a Ubl with Many Targets and promotes the transfer of ubiquitin, directly or indi-
rectly, from a thiolester intermediate to amide linkagesOne of the most intriguing of the Ubls is SUMO (small
ubiquitin-related modifier) (Melchior, 2000). In verte- with proteins or polyubiquitin chains.” (Hershko and Cie-
chanover, 1998). These differences have raised thebrates there are several variants of SUMO (SUMO-1,
-2, and -3), while in the budding yeast Saccharomyces question of whether SUMO ligation to proteins is mecha-
nistically distinct from ubiquitin ligation. In particular, itcerevisiae, there is only one, encoded by the SMT3 gene,
which is essential for progression through the cell cycle. seemed possible that no E3-like factors were needed
for substrate-specific sumoylation.The only known substrates to date for SUMO in yeast
are several members of a family of GTP binding proteins New findings reported by Johnson and Gupta in the
past issue of Cell (Johnson and Gupta, 2001), by Yasudacalled septins, which assemble at the neck between
mother and daughter cells and are essential for cell and colleagues in Molecular Cell (Kahyo et al., 2001),
separation (Takahashi et al., 1999; Johnson and Blobel, and by Takahashi et al. in Gene (Takahashi et al., 2001)
1999). The septins are specifically sumoylated during now demonstrate that the apparent dispensibility of E3-
the G2/M phase of the cell cycle, which is precisely the like factors for protein sumoylation was illusory. All three
point where cells arrest if they are unable to conjugate groups identified structurally related factors from either
SUMO. Surprisingly, however, preventing septin sumo- yeast or human cells that are capable of greatly stimulat-
ylation by mutating all the major SUMO addition sites ing substrate-specific SUMO ligation both in vivo and
does not block, or even delay, the cell cycle (Johnson in vitro. Their results further highlight the mechanistic
and Blobel, 1999). parallels between protein sumoylation and ubiquitina-
The first substrate found for SUMO was the vertebrate tion, but they also raise new questions about how SUMO
nucleocytoplasmic transport factor RanGAP1, and a is ligated to particular proteins and what functions su-
number of additional vertebrate substrates were identi- moylation serves.
fied soon thereafter (Melchior, 2000). But it was in yeast E3-like Proteins for SUMO Conjugation
Kahyo et al. and Takahashi et al. both found their way
to their E3-like factors via yeast two-hybrid interaction1Correspondence: mark.hochstrasser@yale.edu
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one or two (or any) zinc ions and to verify that it folds
into a RING-like conformation.
In the most complete of the three new studies, John-
son and Gupta (2001) provide convincing evidence that
Siz1 is an E3-like protein that promotes SUMO attach-
ment to specific proteins. Recombinant E1, E2, and Siz1
purified from E. coli are able to synthesize polySUMO
chains from monomeric SUMO; more importantly, since
the significance of SUMO chains is unknown, the same
set of proteins can catalyze sumoylation of a highly
purified septin preparation from yeast. Siz1 binds to the
E2 Ubc9 and appears to bind, directly or indirectly, to
septins (Takahashi et al., 2001). In vivo, Siz1 is specifi-
cally required for septin modification whereas Siz2 is
needed for the sumoylation of an unidentified 27 kDa
protein. Thus, all the criteria defining an E3 are satisfied.Figure 1. The SUMO Cycle
From the other two studies one can add the conclusionsEnzyme names are from S. cerevisiae, where most of the compo-
that the SP-RING domain is necessary for stimulationnents were first described.
of SUMO ligation, and in particular, is required for Ubc9
binding, which is reminiscent of ubiquitin E3 RING finger
association with E2. Collectively, these results stronglyscreens for proteins that bound to SUMO. Johnson and
imply that SP-RINGs function in sumoylation in a mannerGupta, on the other hand, simply made an educated
that is mechanistically similar to their ubiquitin pathwayguess based on an obscure entry logged in the Saccha-
cousins.romyces Genome Database website, which noted an
A clear difference remains, however. At high concen-otherwise uncharacterized protein, Nfi1, that was said
trations of E1 and E2, the Siz1 protein is no longer re-to interact with the septin Cdc12. Although deletion of
quired for efficient substrate modification in vitro, andthe NFI1 gene (subsequently renamed SIZ2) had no im-
even at lower E1 and E2 levels, a small amount of septinpact on the level of sumoylated septins, removal instead
sumoylation was still detectable in the absence of Siz1 inof a related gene, SIZ1/ULL1, severely reduced SUMO
vitro and in vivo (see Takahashi et al., 2001). In contrast,attachment to all three of the septins that are normally
ubiquitin E3s are essential for substrate targeting. Doessumoylated (Johnson and Gupta, 2001). Takahashi et
this mean that the ubiquitin and SUMO E3s function inal. (2001) arrived at SIZ1/ULL1 by a similar route follow-
fundamentally different ways? The answer is—probablying the observation of a two-hybrid interaction between
not. Ubiquitin RING E3s are thought to act by bringingNfi1/Siz2 and SUMO. The mammalian proteins to which
the E2 and substrate into close spatial proximity to allowSiz1 and Siz2 are most closely related are the PIAS
ubiquitin transfer from the E2 to the attacking lysine side
(protein inhibitor of activated STAT) proteins, and it was
chain of the substrate, so a contribution of the E2 to
PIAS1 that Kahyo et al. identified as a potential E3-like
substrate binding is not unreasonable. It is likely that a
protein for sumoylation of the p53 tumor suppressor in
continuum exists in the distribution of substrate binding
human cells. interactions deriving from the E2 versus E3 components
What led all these investigators to the idea that Siz1, in E2/E3 ubiquitin-conjugation complexes. The SUMO
Siz2, and PIAS1 might be E3-like factors was the modest pathway may be shifted toward the end of the spectrum
similarity of a conserved internal segment of these pro- where a substantial part of the binding energy comes
teins to the RING finger, a motif that defines the largest from the E2. Having the E2 play a larger role in substrate
subfamily of ubiquitin E3s (Hershko and Ciechanover, recognition might be the more “primitive” situation
1998). RING fingers bind a pair of zinc atoms in a distinc- among the Ubl ligation systems since in the ancestral
tive “cross-brace” arrangement of coordinating Cys and modification system(s), E2-like proteins probably tar-
His residues, creating a globular domain that can di- geted substrates without an E3. E3-like factors likely
rectly bind E2s. However, the Siz/PIAS RING (SP-RING) arose later, allowing for enhanced or expanded specific-
lacks two of the cysteines that are conserved in all ities—or in some cases taking over the task of substrate
known RING E3s, so it remains to be demonstrated that discrimination almost entirely (Hochstrasser, 2000).
it has the same general structure as a classical RING. It Analysis of additional SUMO substrates and other Ubl
is noteworthy that mutation of several zinc-coordinating conjugation systems will be necessary to test these con-
cysteines in the BRCA1 RING finger does not abolish jectures.
zinc binding (Brzovic et al., 2001), and that the RING in What Does SUMO Modification Do?
Mdm2, a ubiquitin E3, has a threonine instead of a cys- Although there are many similarities in the biochemistry
teine at one of the coordinating positions (see Kahyo of ubiquitin and SUMO ligation, we are at an early stage
et al., 2001). Furthermore, a motif called the U box is in deciphering what SUMO attachment actually does for
predicted to have a fold very similar to that of a RING a protein. Most generally, we would like to know the
finger despite lacking all the metal-coordinating resi- molecular basis for the functional differences between
dues; recently, several U box proteins were shown to SUMO-linked proteins and their nonconjugated forms.
have E3 ubiquitin-ligase activity (Hatakeyama et al., In addition, however, it will be important to determine
2001). It will be interesting to determine the three-dimen- exactly which proteins are sumoylated, when and where
the modification occurs, and how the sumoylation ofsional structure of the SP-RING to see if it coordinates
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individual substrates contributes to a particular physio- In Vivo Function of SUMO E3s
Similarly, very little is known about the physiologicallogical process, such as cell cycle progression or
nucleocytoplasmic trafficking. roles of Siz1 and Siz2. Neither Siz protein is essential
for yeast viability, in contrast to several other enzymesConcerning mechanisms for the functional alteration
of proteins by SUMO, two general models have gained in the yeast SUMO pathway, although the siz1 siz2
double mutant grows poorly at low temperatures. Inter-currency. The first and most obvious idea is that a
SUMO-protein conjugate can acquire an altered affinity estingly, Siz1 was initially identified in studies that linked
it genetically to the condensin complex, which orches-for a particular ligand. For example, sumoylated Ran-
GAP1 appears to bind preferentially to the nuclear pore trates mitotic chromosome condensation (Strunnikov et
al., 2001). Consistent with this, most of Siz1 localizescomplex (NPC) relative to either free SUMO or RanGAP1
(Melchior, 2000). The enhanced binding could be due to the nucleus. In contrast to the relative paucity of
information on yeast SP-RING protein biology, a stringto increased avidity for the NPC provided by multiple
binding sites in both SUMO and RanGAP1, interference of papers has detailed possible biological functions for
the various metazoan versions (Table 1). The closestby SUMO attachment with a factor that limits RanGAP1
access to the NPC, conformational changes in either link to the yeast work on Siz1 is a recent report that the
lone member of the PIAS family in Drosophila, calledpartner protein that expose or create an NPC binding
site, or some combination of these mechanisms. The dPIAS, Su(var)2-10, or Zimp, is required for normal mi-
totic chromosome condensation and interphase chro-second model for SUMO function, for which there is
also experimental evidence, holds that SUMO ligation mosome organization (Hari et al., 2001). Loss of dPIAS
is lethal, and it has been shown to be required for normalto a substrate can block attachment of ubiquitin (or
another Ubl) to the same substrate, possibly by competi- blood cell and eye development (Betz et al., 2001).
In mammals, the PIAS proteins, which are encodedtion for the same lysine residue. Support for such a
mechanism comes from studies of the IB and Mdm2 by a small gene family, were first identified as transcrip-
tional coregulators (Greenhalgh and Hilton, 2001). In theproteins. A large fraction of Mdm2, for instance, is nor-
mally sumoylated on a specific lysine in the Mdm2 RING JAK-STAT signal transduction pathway, assembly of
specific receptor complexes after ligand binding leadsfinger (Buschmann et al., 2000). In its nonsumoylated
form, the Mdm2 ubiquitin ligase is prone to catalyze its to activation of receptor-associated kinases of the Ja-
nus (JAK) family, which then recruit and phosphorylateown polyubiquitination and destruction. Because Mdm2
negatively regulates the p53 tumor suppressor, such a DNA binding transcription factors of the STAT family.
This results in dimerization of the STATs followed byreduction in Mdm2 sumoylation will tend to increase
levels of p53 and p53’s growth inhibitory activity. Indeed, their translocation into the nucleus and transcriptional
activation. Downregulation of the pathway occurs byRonai and colleagues found that inflicting DNA damage
on cells by exposure to radiation, which is known to several means, including direct binding of the activated
STAT dimer by members of the PIAS family, which inenhance p53 stability, impairs Mdm2 sumoylation (or
enhances its desumoylation) and this in turn correlates most—but not all—cases prevents STAT-DNA binding.
PIAS proteins can also play positive roles in transcrip-with an increase in p53 levels (Buschmann et al., 2000).
Unfortunately, for situations where SUMO is not sim- tion, and one of the PIAS proteins, PIAS1 or GBP, has
been isolated by its ability to bind to a nucleolar RNAply competing with ubiquitin or another Ubl for modifica-
tion of a protein, the physiological significance of protein helicase, called Gu/RNA helicase II (Valdez et al., 1997).
Remarkably, when GBP associates with the helicase,sumoylation has generally remained obscure. RanGAP1
again serves as an instructive example. Although su- proteolytic cleavage of the helicase is triggered. As in
all of the other examples above, the participation ofmoylated RanGAP1 clearly concentrates at the cyto-
plasmic fibrils of the NPC and such localization depends SUMO ligation in these biochemical events is not yet
known.on its sumoylation, why RanGAP1 must localize to the
NPC and whether a failure to do so has any functional Most tantalizing of the SP-RING factors with respect
to the SUMO pathway is a rat protein called ARIP3 (an-consequence are still not known with certainty (Mel-
chior, 2000). Yeast RanGAP1, for comparison, is neither drogen receptor interacting protein), which appears to
be the ortholog of PIASx in humans (Moilanen et al.,sumoylated nor localized to the NPC. Other substrates
are even more problematic. The p53 transcription factor, 1999). Unlike the aforementioned SP-RING binding pro-
teins, the protein to which ARIP3 was found to bind, thewhich was the substrate used by Kahyo et al. to evaluate
PIAS1 sumoylation-enhancing activity, is subject to a androgen receptor (AR), has also been shown to be
sumoylated on a specific lysine in vivo (Poukka et al.,low level of sumoylation in vivo, and the major modifica-
tion site has been mapped. In the original reports on 2000). Mutation of this residue blocks sumoylation and
enhances transcriptional activity of AR, suggesting thatp53 sumoylation, mutation of the target lysine to an
arginine, which blocks SUMO addition, prevented the SUMO modification negatively regulates AR activity. The
target lysine is part of a KxE consensus site, which,modestly enhanced transactivation activity of p53 that is
caused by augmenting cellular SUMO levels, but several interestingly, is identical to something called the “tran-
scriptional synergy control motif” (see Poukka et al.,laboratories have not been able to reproduce this result
(Kwek et al., 2001 and references therein). Even the 2000). Not only AR but several other members of the
steroid receptor superfamily have this motif, raising theelegant studies on yeast septin sumoylation have failed
to reveal the purpose of this modification (Johnson and possibility that SUMO modification may modulate a host
of different nuclear receptor transcription factors, withBlobel, 1999). Clearly, understanding SUMO function at
a molecular level will require considerable additional the SP-RING proteins presumably helping to direct the
modification.analysis.
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Table 1. Regulatory Pathways Linked to the SP-RING Family of (Putative) SUMO Ligases
SP-RING
Protein Alternative Names Organism Pathways or Substrates Ref.
Siz1 Ull1, YDR409w S. cerevisiae septins (Cdc3, Cdc11, Sep7) a, b
Siz2 Nfi1, YOR156c S. cerevisiae unknown; required with Siz1 for growth a, b
at low temperature
PIAS1 GBP H. sapiens, binds STAT1, Gu/RNA helicase II; c, d, e
M. musculus stimulates p53 sumoylation
PIAS3 KChAP M. musculus binds K channels, STAT3 c, f
H. sapiens
R. norvegicus
PIASx ARIP3 Miz1, M. musculus binds STATx; androgen receptor, c, g
Disabled 2-inter- H. sapiens which is sumoylated; mouse
acting protein R. norvegicus Disabled-2 p67 isoform; Msx2
dPIAS Su(var)2-10, Zimp D. melanogaster binds Drosophila stat92E; required for h, i
chromosome condensation,
structure; essential for development
a Johnson and Gupta (2001); b Takahashi et al. (2001); c Greenhalgh and Hilton (2001); d Kahyo et al. (2001); e Valdez et al. (1997); f Kuryshev et
al. (2000); g Moilanen et al. (1999); h Hari et al. (2001); i Betz et al. (2001).
Brzovic, P.S., Meza, J.E., King, M.C., and Klevit, R.E. (2001). J. Biol.Although the SP-RING proteins loiter primarily in the
Chem. Published online Aug. 28, 2001. 10.0174/jbc.M106551200.nucleus and seem to have many roles there, yeast Siz1
Buschmann, T., Fuchs, S.Y., Lee, C.G., Pan, Z.Q., and Ronai, Z.can also localize near the plasma membrane in the bud
(2000). Cell 101, 753–762.neck region during part of the cell cycle. Furthermore,
Greenhalgh, C.J., and Hilton, D.J. (2001). J. Leukoc. Biol. 70,a mammalian SP-RING factor, PIAS3 or KChAP, has
348–356.been found to interact transiently with a subset of volt-
Hari, K.L., Cook, K.R., and Karpen, G.H. (2001). Genes Dev. 15,age-regulated potassium channels (Kuryshev et al.,
1334–1348.
2000). KChAP is believed to function as a kind of molecu-
Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N., and Naka-lar chaperone, enhancing channel biogenesis by a
yama, K.I. (2001). J. Biol. Chem. 276, 33111–33120.
mechanism that has not yet been ascertained. It will
Hershko, A., and Ciechanover, A. (1998). Annu. Rev. Biochem. 67,
clearly be of interest to determine if the putative SUMO 425–479.
E3 activity of the protein contributes to this unusual
Hochstrasser, M. (2000). Nat. Cell Biol. 2, E153–E157.
chaperoning property.
Johnson, E.S., and Blobel, G. (1999). J. Cell Biol. 147, 981–994.What Next?
Johnson, E.S., and Gupta, A.A. (2001). Cell 106, 735–744.The discovery of SUMO ligation activity for the wide-
Kahyo, T., Nishida, T., and Yasuda, H. (2001). Mol. Cell 8, 713–718.spread and highly conserved SP-RING family of proteins
Kuryshev, Y.A., Gudz, T.I., Brown, A.M., and Wible, BA. (2000). Am.is an exciting development for the many researchers
J. Physiol. Cell Physiol. 278, C931–C941.who have been working on these proteins in various
Kwek, S.S., Derry, J., Tyner, A.L., Shen, Z., and Gudkov, A.V. (2001).biological contexts. What is clearly missing from all the
Oncogene 20, 2587–2599.studies to date is an understanding of how this enzy-
Melchior, F. (2000). Annu. Rev. Cell Dev. Biol. 16, 591–626.matic activity of these proteins relates to their specific
Moilanen, A.M., Karvonen, U., Poukka, H., Yan, W., Toppari, J.,biological functions. As the painstaking analysis of yeast
Janne, O.A., and Palvimo, J.J. (1999). J. Biol. Chem. 274, 3700–3704.septin sumoylation has made clear, establishing such
Poukka, H., Karvonen, U., Janne, O.A., and Palvimo, J.J. (2000).relationships can sometimes be quite frustrating. Other
Proc. Natl. Acad. Sci. USA 97, 14145–14150.
major questions are how many SUMO E3s exist and will
Strunnikov, A.V., Aravind, L., and Koonin, E.V. (2001). Genetics 158,they all be part of the same structural family. Yeast
95–107.
appear to have no SP-RING proteins other than Siz1
Takahashi, Y., Iwase, M., Konishi, M., Tanaka, M., Toh-e, A., and
and Siz2, yet sumoylation is still detected in vivo in the Kikuchi, Y. (1999). Biochem. Biophys. Res. Commun. 259, 582–587.
absence of these two enzymes. Although it is possible
Takahashi, Y., Toh-e, A., and Kikuchi, Y. (2001). Gene 275, 223–231.
that this reflects E3-independent SUMO conjugation by
Valdez, B.C., Henning, D., Perlaky, L., Busch, R.K., and Busch, H.
Ubc9, the existence of additional, non-SP-RING E3s (1997). Biochem. Biophys. Res. Commun. 234, 335–340.
seems more likely. Several classical RING proteins from
yeast, for example, have been isolated by large scale
two-hybrid screens with SUMO as bait, and non-RING
E3s are also possible. What is clear at this point is that
SUMO ligation is emerging as a critical factor in cellular
processes ranging from cell cycle regulation to tran-
scriptional control, and we can expect to hear much
more about this fascinating protein modification system
in the coming years.
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